Also available in Persian — نسخه فارسی ✈️ Telegram EN فا
❓ Unknown

Commonly mutated gene could be a therapeutic target in sarcoma

Just now November 19, 2026 1 min read 📰 Medical Xpress
📋 Key Takeaway

This article is not relevant to Iranian affairs. It reports on cancer research findings from a U.S. medical institution regarding sarcoma treatment and the ATRX gene, with no connection to Iran, Iranian politics, or Iranian society.

Researchers at The University of Texas MD Anderson Cancer Center have discovered that sarcomas lacking the ATRX gene tend to be more aggressive and may be particularly vulnerable to a class of targeted therapies known as TEAD inhibitors. The findings identify ATRX loss as both a marker of poor prognosis and a potential therapeutic target.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →